MILLA PHARMS
GenericsMILLA PHARMS is a generic drug manufacturer focused on Neurology, Cardiovascular, Metabolic.
MILLA PHARMS's Key Drugs
MILLA PHARMS's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
MILLA PHARMS's Recent FDA Approvals
MILLA PHARMS secured 1 new FDA approval for novel drugs (NDA/BLA) in the last two years.
MILLA PHARMS's Therapeutic Areas
MILLA PHARMS's approved drugs and pipeline span 3 therapeutic areas, led by Neurology and Cardiovascular, across 0 biologic and 0 small-molecule drugs. Weighted by commercial stage — approved drugs count most, then late-stage trials.
MILLA PHARMS's Top Competitors
MILLA PHARMS's closest competitors by therapeutic-area and drug-target overlap include Novo Nordisk, AZURITY, and Merck. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
MILLA PHARMS Pipeline Snapshot
Active clinical trials for MILLA PHARMS across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Neurology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2017-01-13
- Latest
- 2024-12-31
- Applications
- 10